Compare RNAZ & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNAZ | CLPS |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 31.6M |
| IPO Year | 2021 | 2017 |
| Metric | RNAZ | CLPS |
|---|---|---|
| Price | $1.80 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.3K | 6.3K |
| Earning Date | 08-14-2026 | 10-16-2026 |
| Dividend Yield | N/A | ★ 12.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.52 | $0.80 |
| 52 Week High | $15.33 | $1.24 |
| Indicator | RNAZ | CLPS |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 49.58 |
| Support Level | $1.55 | $0.86 |
| Resistance Level | $2.39 | $1.04 |
| Average True Range (ATR) | 0.17 | 0.02 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 68.29 | 40.08 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.